1. Home
  2. GPGI vs IBRX Comparison

GPGI vs IBRX Comparison

Compare GPGI & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GPGI

GPGI Inc.

N/A

Current Price

$17.10

Market Cap

7.2B

Sector

N/A

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.59

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPGI
IBRX
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GPGI
IBRX
Price
$17.10
$7.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
N/A
$12.57
AVG Volume (30 Days)
4.7M
24.1M
Earning Date
03-12-2026
05-11-2026
Dividend Yield
0.06%
N/A
EPS Growth
N/A
38.71
EPS
N/A
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$770.85
$88.59
Revenue Next Year
$125.54
$131.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
668.31
52 Week Low
$15.84
$1.83
52 Week High
$25.66
$12.43

Technical Indicators

Market Signals
Indicator
GPGI
IBRX
Relative Strength Index (RSI) 38.48 48.47
Support Level $16.41 $2.25
Resistance Level $18.51 $8.28
Average True Range (ATR) 0.94 0.93
MACD 0.04 -0.24
Stochastic Oscillator 40.88 39.00

Price Performance

Historical Comparison
GPGI
IBRX

About GPGI GPGI Inc.

GPGI Inc is a diversified holding platform comprising businesses operating in multiple industries. The platform focuses on acquiring, owning, and scaling operating companies. It currently includes CompoSecure and Husky Technologies. CompoSecure provides technology and manufacturing solutions related to metal payment cards, security, and authentication. Its products and services are used by financial institutions, fintech companies, and other customers. Husky designs and manufactures industrial equipment and provides aftermarket services. Its equipment is used in the production of plastic products, including beverage and food containers, medical devices, and consumer electronics components.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: